e8vk
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 26, 2008
Gen-Probe Incorporated
(Exact Name of Registrant as Specified in Charter)
         
Delaware   001-31279   33-0044608
(State or Other Jurisdiction of   (Commission   (I.R.S. Employer
Incorporation)   File Number)   Identification No.)
     
10210 Genetic Center Drive    
San Diego, CA   92121
(Address of Principal Executive Offices)   (Zip Code)
 
(858) 410-8000
(Registrant’s telephone number, including area code)
 
          Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
  o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
  o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
  o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
  o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

 

Item 8.01. Other Events.
          On August 26, 2008, Gen-Probe Incorporated (the “Company”) announced that its Board of Directors has authorized a plan to repurchase up to $250 million of the Company’s common stock over the next two years. Under the plan, repurchases may occur from time to time on the open market or through private transactions, pursuant to Rule 10b5-1 trading plans or other available means, at the Company’s discretion. A copy of the Company’s news release announcing the repurchase plan is attached as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
     (d) Exhibits:
     
Exhibit Number   Description
 
    
99.1
  News release dated August 26, 2008

 

 

SIGNATURE
          Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
             
Date: August 26, 2008   GEN-PROBE INCORPORATED    
 
            
 
  By:   /s/ R. William Bowen    
 
           
 
      R. William Bowen    
 
      Senior Vice President, General Counsel and Corporate Secretary    

 

 

EXHIBITS
     
Exhibit Number   Description
 
    
99.1
  News release dated August 26, 2008